Showing results (231-240 of 260) with videos related to

Sort By:
Pageof 26
Nature Medicine|July 2, 2002
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironmentKoichi Hattori, Beate Heissig, Yan Wu, et al.
Journal of Environmental Radioactivity|February 28, 2025
Conversion of hydrogen gas to water in soil: Implications to fusion contributionsE R Edwards, B J Viner, M C Duff, et al.
Human Gene Therapy|December 22, 2004
Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosisRonald G Crystal, Dolan Sondhi, Neil R Hackett, et al.
Gene Therapy|July 30, 2005
AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCLD Sondhi, D A Peterson, E L Giannaris, et al.
Human Gene Therapy|December 26, 2024
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene TherapyMaria Gioulvanidou, Selenay Sarklioglu, Xinlei Chen, et al.
Cancer Gene Therapy|December 16, 2014
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastomaMartin J Hicks, Kosuke Funato, Lan Wang, et al.
Breast Cancer Research and Treatment|May 1, 2007
Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patientsJenny C Chang, Andreas Makris, M Carolina Gutierrez, et al.
Human Mutation|October 15, 2013
Exome sequencing identifies potential risk variants for Mendelian disorders at high prevalence in QatarJuan L Rodriguez-Flores, Khalid Fakhro, Neil R Hackett, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 3, 2006
Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosisMarco A Passini, James C Dodge, Jie Bu, et al.
Nature Medicine|November 2, 2001
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthD Lyden, K Hattori, S Dias, et al.
Pageof 26